BioCryst Pharmaceuticals
BCRX
#4609
Rank
A$3.41 B
Marketcap
A$13.45
Share price
3.40%
Change (1 day)
3.09%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): A$0.39 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are A$0.87 Billion. , an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.38 B-407.51%
2024 -A$0.13 Billion-61.56%
2023 -A$0.33 Billion-7.43%
2022 -A$0.35 Billion34.42%
2021 -A$0.26 Billion-0.55%
2020 -A$0.27 Billion67.88%
2019 -A$0.16 Billion7.55%
2018 -A$0.15 Billion53.92%
2017 -A$93.96 Million19.29%
2016 -A$78.77 Million28.19%
2015 -A$61.45 Million-4.8%
2014 -A$64.55 Million50.09%
2013 -A$43.01 Million-23.29%
2012 -A$56.07 Million-26.19%
2011 -A$75.96 Million54.78%
2010 -A$49.08 Million150.1%
2009 -A$19.63 Million-49.43%
2008 -A$38.8 Million14.07%
2007 -A$34.02 Million-49.31%
2006 -A$67.11 Million72.87%
2005 -A$38.82 Million22.08%
2004 -A$31.8 Million75.3%
2003 -A$18.14 Million-25.36%
2002 -A$24.31 Million225.05%
2001 -A$7.48 Million-56.6%
2000 -A$17.23 Million50.63%
1999 -A$11.44 Million38.05%
1998 -A$8.29 Million-52.46%
1997 -A$17.43 Million58.44%
1996 -A$11 Million-14.44%
1995 -A$12.86 Million28.57%
1994 -A$10 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$13.99 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.29 B 3,644.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$1.01 Billion-362.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.11 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.66 B 73.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.61 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.37 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA